Rachael L Parke1, Shay P McGuinness. 1. Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
Abstract
BACKGROUND:Nasal high flow (NHF) oxygen therapy and CPAP are modes of noninvasive respiratory support used to improve respiratory function in multiple patient groups. Both therapies provide positive pressure, although this varies during the respiratory cycle. The purpose of this study was to measure and compare the airway pressure generated during different phases of the respiratory cycle in patients receiving NHF at various gas flows. METHODS:Patients scheduled for elective cardiac surgery were invited to participate. Nasopharyngeal pressure measurements were performed using NHF with gas flows of 30, 40, and 50 L/min. All measurements were performed in random order, with the subject breathing with mouth closed. RESULTS: During NHF the mean ± SD nasopharyngeal airway pressures were 1.5 ± 0.6, 2.2 ± 0.8, and 3.1 ± 1.2 at 30, 40, and 50 L/min using NHF. Analyses also determined the mean peak expiratory and mean expiratory plateau pressures. CONCLUSIONS: The expiratory pressure during NHF was higher than the mean pressure previously reported for NHF. This may account in part for the disproportional clinical effects seen with NHF. (Australian Clinical Trials Registry www.anzctr.org.au ACTRN12609000305224).
RCT Entities:
BACKGROUND: Nasal high flow (NHF) oxygen therapy and CPAP are modes of noninvasive respiratory support used to improve respiratory function in multiple patient groups. Both therapies provide positive pressure, although this varies during the respiratory cycle. The purpose of this study was to measure and compare the airway pressure generated during different phases of the respiratory cycle in patients receiving NHF at various gas flows. METHODS:Patients scheduled for elective cardiac surgery were invited to participate. Nasopharyngeal pressure measurements were performed using NHF with gas flows of 30, 40, and 50 L/min. All measurements were performed in random order, with the subject breathing with mouth closed. RESULTS: During NHF the mean ± SD nasopharyngeal airway pressures were 1.5 ± 0.6, 2.2 ± 0.8, and 3.1 ± 1.2 at 30, 40, and 50 L/min using NHF. Analyses also determined the mean peak expiratory and mean expiratory plateau pressures. CONCLUSIONS: The expiratory pressure during NHF was higher than the mean pressure previously reported for NHF. This may account in part for the disproportional clinical effects seen with NHF. (Australian Clinical Trials Registry www.anzctr.org.au ACTRN12609000305224).
Entities:
Keywords:
airway pressure; nasal high flow oxygen; noninvasive ventilation; oxygen
Authors: Bernd E Winkler; Ralf M Muellenbach; Thomas Wurmb; Manuel F Struck; Norbert Roewer; Peter Kranke Journal: J Clin Monit Comput Date: 2016-02-09 Impact factor: 2.502
Authors: Jason L Siegel; Karen Hampton; Alejandro A Rabinstein; Diane McLaughlin; Jose L Diaz-Gomez Journal: Neurocrit Care Date: 2018-12 Impact factor: 3.210
Authors: Weiqing Jiang; Li Shi; Qian Zhao; Wenwen Zhang; Man Xu; Wanling Wang; Xiaoliang Wang; Hongguang Bao; Jing Leng; Li Jiang Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2020-11-30
Authors: Tommaso Mauri; Laura Alban; Cecilia Turrini; Barbara Cambiaghi; Eleonora Carlesso; Paolo Taccone; Nicola Bottino; Alfredo Lissoni; Savino Spadaro; Carlo Alberto Volta; Luciano Gattinoni; Antonio Pesenti; Giacomo Grasselli Journal: Intensive Care Med Date: 2017-07-31 Impact factor: 17.440